Haoxi Health Technology Ltd current report, Q2 FY2024

Haoxi Health Technology Limited — Form 6-K Summary

Business Context and Reporting Period

Haoxi Health Technology Limited filed a Form 6-K for May 2024. The filing reports unaudited financial results for the six months ended December 31, 2023 and discusses recent corporate developments. The filing identifies the company as a foreign private issuer that files annual reports on Form 20-F. The referenced press release was dated May 31, 2024.

Financial Metrics

The supplied filing text does not include the referenced Exhibit 99.1 press release or its financial statements. Accordingly, revenue, net income or loss, cash flow, margins, debt, liquidity, and other financial metrics are not provided clearly in the available text.

Material Changes Versus Prior Period

The filing states that financial results for the six months ended December 31, 2023 are being reported, but it does not provide comparative-period figures or describe specific year-over-year changes in the supplied text.

Guidance, Outlook, Risks, and Unusual Items

The filing contains standard forward-looking-statement cautionary language. Management warns that actual results may differ materially because of product and service demand and acceptance, technological changes, economic conditions, competition and pricing, government regulation, and other risks described in the company’s SEC filings.

The filing does not provide specific financial guidance, forecasts, contingencies, or unusual items in the available text. The company states that it undertakes no obligation to update forward-looking statements.

Investor Verification Items

  • Obtain and review Exhibit 99.1 for the complete unaudited financial results for the six months ended December 31, 2023.
  • Verify revenue, profitability, operating cash flow, cash balance, debt, liquidity, and comparative-period figures.
  • Review the company’s recent corporate developments and any management outlook included in the missing exhibit.
  • Assess the risks relating to demand, competition, pricing, regulation, technology, and broader economic conditions.
  • Confirm whether subsequent SEC filings provide audited results, restatements, material events, or updates to the company’s financial condition.